Bayesian Capital Management’s Houghton Mifflin Harcourt Company HMHC Stock Holding History

Bayesian Capital Management’s Portfolio HMHC Stock Details HMHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-20,450	Closed	-$430K	–	1198
2022 Q1	$430K	Buy	+20,450	New	+$385K	0.06%	419
2019 Q2	–	Sell	-13,700	Closed	-$100K	–	725
2019 Q1	$100K	Buy	+13,700	New	+$123K	0.02%	508
2018 Q2	–	Sell	-15,900	Closed	-$111K	–	784
2018 Q1	$111K	Sell	15,900 -200	-1%	-$1.58K	0.03%	530
2017 Q4	$150K	Buy	+16,100	New	+$161K	0.03%	503

Other funds holding HMHC

Repertoire Partners New York $143M AUM 28.83% 1-Year Est. Return

Bayesian Capital Management's HMHC Position: Q2 2022 in Review

Bayesian Capital Management sold out of Houghton Mifflin Harcourt Company (HMHC) in Q2 2022, closing a stake of 20,450 shares — an estimated $430K sold.

Bayesian Capital Management first reported a position in HMHC in Q4 2017 and held it in 4 quarters. The position peaked at $430K in Q1 2022. 1 fund tracked by Wall St. Rank holds HMHC as of Q2 2022.

Bayesian Capital Management reported no remaining Houghton Mifflin Harcourt Company position as of Q2 2022 after selling out during the quarter.
Bayesian Capital Management sold 20,450 Houghton Mifflin Harcourt Company shares in Q2 2022, an estimated $430K.
Bayesian Capital Management first reported a position in Houghton Mifflin Harcourt Company in Q4 2017 and held it in 4 quarters.
Bayesian Capital Management's Houghton Mifflin Harcourt Company position peaked at $430K in Q1 2022.
1 fund tracked by Wall St. Rank held Houghton Mifflin Harcourt Company as of Q2 2022.

Based on Bayesian Capital Management's 13F filing for Q2 2022, filed 15 Aug 2022.